Status:

TERMINATED

Prospective Study Deltamotion - DAA THA Study

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Collaborating Sponsors:

DePuy International

Conditions:

Arthrosis

Eligibility:

All Genders

20-75 years

Brief Summary

1. Introduction Few gait analytical data are available concerning the Direct Anterior Approach (DAA) in total hip arthroplasty (THA). All the studies have focused on immediate post-operative recovery....

Detailed Description

Estimated inclusion time: 1 July 2011 - 31 December 2013 Cohorts: 20 DAA subjects - 20 control subjects Assessments: * Time interval: pre-op - 3m - 6m - 12m * Gait analysis with surface EMG and trun...

Eligibility Criteria

Inclusion

  • Age: 20-75 years
  • BMI: \< 30kg/m2
  • Diagnosis: unilateral primary and secondary osteoarthritis treated with the Deltamotion THA with a Corail stem

Exclusion

  • Osteoarthritis other joints and low back impairment
  • LLD \> 5mm

Key Trial Info

Start Date :

October 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2013

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT01474031

Start Date

October 1 2011

End Date

July 1 2013

Last Update

November 18 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UZ Pellenberg

Leuven, Belgium, 3000